--- title: "Wound Care, Definition | MedTech Terms" description: "Devices and biologics for managing acute and chronic wounds. Plain-English Market Segments definition for MedTech teams, with examples and related terms." lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/wound-care#term", "name": "Wound Care", "description": "Wound care includes negative-pressure wound therapy (NPWT, e.g., 3M/KCI V.A.C.), advanced dressings, cellular and tissue products (CTPs/skin substitutes), and emerging electrical stimulation and oxygen therapies.", "url": "https://medtechterms.com/terms/wound-care", "termCode": "wound-care", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/wound-care#article", "headline": "Wound Care", "description": "Devices and biologics for managing acute and chronic wounds.", "url": "https://medtechterms.com/terms/wound-care", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/wound-care" }, "about": { "@id": "https://medtechterms.com/terms/wound-care#term" }, "articleSection": "Market Segments", "inLanguage": "en", "keywords": "Wound Care, Market Segments, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-05-05", "dateModified": "2026-05-05", "citation": [ { "@type": "CreativeWork", "name": "WoundSource", "url": "https://www.woundsource.com/", "publisher": { "@type": "Organization", "name": "WoundSource" } }, { "@type": "CreativeWork", "name": "MedTech Dive", "url": "https://www.medtechdive.com/", "publisher": { "@type": "Organization", "name": "MedTech Dive" } }, { "@type": "CreativeWork", "name": "AdvaMed - Industry Reports", "url": "https://www.advamed.org/our-work/", "publisher": { "@type": "Organization", "name": "AdvaMed" } } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Market Segments", "item": "https://medtechterms.com/terms?cat=Market%20Segments" }, { "@type": "ListItem", "position": 4, "name": "Wound Care", "item": "https://medtechterms.com/terms/wound-care" } ] }, { "@type": "FAQPage", "@id": "https://medtechterms.com/terms/wound-care#faq", "mainEntity": [ { "@type": "Question", "name": "What is Negative Pressure Wound Therapy (NPWT)?", "acceptedAnswer": { "@type": "Answer", "text": "NPWT is a therapeutic technique using a vacuum dressing to promote healing in acute or chronic wounds and enhance healing of second and third degree burns. It involves applying controlled negative pressure to the wound bed through a sealed dressing, facilitating fluid removal and promoting tissue granulation." } }, { "@type": "Question", "name": "How are advanced dressings regulated?", "acceptedAnswer": { "@type": "Answer", "text": "Advanced dressings, depending on their composition and intended use (e.g., antimicrobial properties, absorbency), are regulated as medical devices. Their classification (e.g., FDA Class I, II, or EU MDR Class I, IIa) determines the specific pre-market requirements and conformity assessment procedures they must undergo." } }, { "@type": "Question", "name": "What are Cellular and Tissue Products (CTPs)?", "acceptedAnswer": { "@type": "Answer", "text": "CTPs, often called skin substitutes, are biological products used to cover wounds and promote healing, particularly for severe burns or chronic ulcers. They can be derived from human, animal, or engineered sources and are subject to rigorous regulatory oversight, such as FDA 21 CFR Part 1271 for human cells, tissues, and cellular and tissue-based products (HCT/Ps)." } } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Market Segments](/terms?cat=Market%20Segments) 6. / 7. Wound Care [All terms](/terms) Market Segments [Strategic Landscape](/ecosystems/strategic-landscape) # Wound Care Devices and biologics for managing acute and chronic wounds. Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 ## Definition Wound care includes negative-pressure wound therapy (NPWT, e.g., 3M/KCI V.A.C.), advanced dressings, cellular and tissue products (CTPs/skin substitutes), and emerging electrical stimulation and oxygen therapies. What the regulation says Wound care products are subject to classification based on their risk to patients, which dictates the regulatory pathway and pre-market submission requirements, as per FDA 21 CFR Part 860 and EU [MDR](/terms/mdr-reporting) Article 51. Devices such as advanced dressings typically fall into lower risk classes, while implantable or biologically derived products, like cellular and tissue products, face more stringent controls and data requirements. Manufacturers must demonstrate safety and effectiveness for their [intended use](/terms/intended-use), aligning with principles found in [ISO 13485](/terms/iso-13485) for quality management systems. ## What this means in practice Diabetic foot ulcers and venous leg ulcers drive demand. CMS LCDs on skin substitutes have repeatedly reshaped commercial dynamics. ## Examples - A company developing an antimicrobial wound dressing must provide biocompatibility data and demonstrate the dressing's effectiveness against relevant pathogens. - A manufacturer of a new electrical stimulation device for chronic wounds needs to conduct clinical trials to prove its safety and efficacy in promoting wound closure. - A cellular therapy product for diabetic foot ulcers requires extensive pre-clinical testing and clinical data to support its claims of tissue regeneration and wound healing. Common pitfalls - • A common pitfall is misclassifying a novel wound care product, leading to incorrect regulatory submissions and delays. Another mistake is failing to adequately validate sterilization processes for sterile wound care devices. Manufacturers often underestimate the clinical data required for advanced wound care therapies, especially those involving biological components. - • Overlooking specific labeling requirements for combination products, such as drug-device wound dressings, can lead to non-compliance. - • Ignoring post-market surveillance data for long-term wound healing outcomes can result in missed opportunities for product improvements or safety signals. ## Frequently asked questions What is Negative Pressure Wound Therapy (NPWT)? NPWT is a therapeutic technique using a vacuum dressing to promote healing in acute or chronic wounds and enhance healing of second and third degree burns. It involves applying controlled negative pressure to the wound bed through a sealed dressing, facilitating fluid removal and promoting tissue granulation. How are advanced dressings regulated? What are Cellular and Tissue Products (CTPs)? ## Related terms Grouped by theme ### More in Market Segments · Same category [ Market Segments Aesthetic & Energy-Based Devices Lasers, RF, ultrasound, cryolipolysis, and IPL systems used for medical and cosmetic indications, body contouring, hair removal, skin tightening, vascular lesions. ](/terms/aesthetics-energy-devices)[ Market Segments AI Imaging Software Software that analyzes medical images to triage, detect, or quantify disease. ](/terms/ai-imaging)[ Market Segments Cardiac Rhythm Management(CRM) Implantable and external devices that monitor and treat cardiac arrhythmias, pacemakers, ICDs, CRT devices, and insertable cardiac monitors. ](/terms/cardiac-rhythm-management)[ Market Segments Cardiovascular Devices Devices for diagnosing, monitoring, or treating cardiovascular disease. ](/terms/cardiovascular) Cited by Where this term appears across MedTech Terms. Ecosystems (1) - [Strategic Landscape](/ecosystems/strategic-landscape) ## Mentioned in recent activity 3 entries PubMed (3) [Medical Device-Related Pressure Injuries: A Systematic Review for Prevalence, Causes, and Risk Factors Since the COVID-19 Pandemic. ](https://pubmed.ncbi.nlm.nih.gov/42155083/) Advances in skin & wound care · 2026-07-01 [Medical adhesive-related skin injury (MARSI) in intensive care: prevalence and associated factors. ](https://pubmed.ncbi.nlm.nih.gov/42247328/) Journal of wound care · 2026-06-02 [Incidence of nasogastric tube-related pressure injury in the intensive care unit. ](https://pubmed.ncbi.nlm.nih.gov/42247325/) Journal of wound care · 2026-06-02 ## Latest in MedTech [View all](/latest?term=wound-care) Recent regulatory actions, publications, and trials matched to this term. Updated daily. - PubMed 2026-07-01 [Medical Device-Related Pressure Injuries: A Systematic Review for Prevalence, Causes, and Risk Factors Since the COVID-19 Pandemic. ](https://pubmed.ncbi.nlm.nih.gov/42155083/) Advances in skin & wound care - PubMed 2026-06-02 [Medical adhesive-related skin injury (MARSI) in intensive care: prevalence and associated factors. ](https://pubmed.ncbi.nlm.nih.gov/42247328/) Journal of wound care - PubMed 2026-06-02 [Incidence of nasogastric tube-related pressure injury in the intensive care unit. ](https://pubmed.ncbi.nlm.nih.gov/42247325/) Journal of wound care ## Primary references 3 sources Link health: 3 verified · last checked 2026-06-20 WoundSource· 1 MedTech Dive· 1 AdvaMed· 1 1. [1 WoundSource Verified WoundSource · woundsource.com ](https://www.woundsource.com/) 2. [2 MedTech Dive Verified MedTech Dive · medtechdive.com ](https://www.medtechdive.com/) 3. [3 AdvaMed - Industry Reports Verified AdvaMed · advamed.org ](https://www.advamed.org/our-work/) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Building a connected device in this segment? Blue Goat Cyber specializes in MedTech cybersecurity across imaging, cardiac, IVD, surgical, and other connected segments. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Market Segments Sources 3 Updated 5/5/2026 [Compare with another term](/compare?a=wound-care) Learn in 60 seconds Card Lesson Quiz Devices and biologics for managing acute and chronic wounds. - · Diabetic foot ulcers and venous leg ulcers drive demand. - · CMS LCDs on skin substitutes have repeatedly reshaped commercial dynamics. Remember this Watch out: A common pitfall is misclassifying a novel wound care product, leading to incorrect regulatory submissions and delays. Another mistake is failing to adequately validate sterilization processes for sterile wound care devices. Manufacturers often underestimate the clinical data required for advanced wound care therapies, especially those involving biological components. You may also need Auto-suggested from Market Segments and shared keywords. - [Neuromodulation ](/terms/neuromodulation) - [Renal Care Devices ](/terms/renal-care-devices) - [Respiratory Devices ](/terms/respiratory-devices) - [Urology Devices ](/terms/urology-devices) - [Aesthetic & Energy-Based Devices ](/terms/aesthetics-energy-devices) - [ENT Devices ](/terms/ent-devices) [All Market Segments terms](/terms?cat=Market%20Segments) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)